Testosterone hexyloxyphenylpropionate
Testosterone hexyloxyphenylpropionate is an androgen and anabolic steroid (AAS) and a testosterone ester. It is or has been marketed under the brand names Androxon, Panteston, and Restandol. Testosterone hexyloxyphenylpropionate is used in androgen replacement therapy primarily for the treatment of male hypogonadism, and is currently under research for use as a male contraceptive.
Pharmacology
As an androgen and anabolic steroid, testosterone hexyloxyphenylpropionate has similar effects to other testosterone esters. It increases muscle mass, strength, and libido, and has effects on mood, energy levels, and fat distribution. It is a prodrug of testosterone and is converted into testosterone in the body.
Chemistry
Testosterone hexyloxyphenylpropionate, like all testosterone esters, is a prodrug of testosterone. It is an esterified variant of testosterone with a hexyloxyphenylpropionate ester attached to the testosterone molecule. This esterification makes the testosterone more soluble in oil, which allows for a slower release and longer half-life when injected.
History
Testosterone hexyloxyphenylpropionate was first described in the literature in 1970. It was developed by Organon International, a pharmaceutical company, and was marketed under the brand names Androxon, Panteston, and Restandol.
Society and culture
Testosterone hexyloxyphenylpropionate is a controlled substance in many countries and is classified as a Schedule III drug in the United States under the Controlled Substances Act. It is also on the World Anti-Doping Agency's list of prohibited substances, and is therefore banned from use in most professional sports.
See also
This article is a Anabolic steroid-related stub. You can help WikiMD by expanding it!
```
This template is designed for marking articles related to anabolic steroids as stubs, indicating that they are short or incomplete articles on the subject of anabolic steroids. By using this template, contributors are encouraged to expand the article to include more comprehensive information on the topic.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD